This is not a complete list of side effects and others may occur.
Ibrance side effects.
Common side effects of ibrance include.
Ibrance palbociclib is a cancer medicine that interferes with the growth and spread of cancer cells in the body ibrance is used in men and women to treat hr positive her2 negative breast cancer that has spread to other parts of the body.
In postmenopausal women ibrance is given in combination with a hormonal medicine such as letrozole in others ibrance is given together with.
Low white blood cell counts are a common side effect of ibrance.
Call your doctor for medical advice about side effects.
Low white blood cell counts are very common when taking ibrance and may cause serious infections that can lead to death.
Less commonly ibrance may cause serious side effects including.
See below for a comprehensive list of adverse effects.
Ibrance is the first fda approved medication in its class.
Infection and pulmonary embolism.
It treats breast cancer that s metastatic hr positive and her2 negative.
Ibrance side effects by likelihood and severity common side effects.
Ibrance is a targeted therapy known as a cdk 4 6 inhibitor.
Severe neutropenia very low white blood cell count.
A high alanine transaminase level.
Our ibrance palbociclib side effects drug center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This document contains side effect information about palbociclib.
Ibrance may cause serious side effects including.
You may report side effects to fda at 1 800 fda 1088.
Decreased neutrophils other side effects include.
Low white blood cell counts neutropenia.
It is not a traditional chemotherapy.
This helps slow the progression of cancer but it can also cause side effects some of which are serious.
If experienced these tend to have a severe expression.
Ibrance palbociclib is a brand name prescription medication.
Taken in combination with certain hormonal therapies ibrance works to put the brakes on cell growth in both healthy and cancer cells.
Your doctor should check your white blood cell counts before and during treatment.
If any of these effects persist or worsen.
Still some people s white blood cell counts may drop so low that they have to decrease the dose or of ibrance or stop treatment.
